8840 WILSHIRE BLVD, BEVERLY HILLS, CA
Market cap: $1.3B (12/18/2025)
Price: $27.81
Announces Pricing of $150 Million Public Offering of Common Stock
Investor Presentation
Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
Earnings Release
Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy
Material disclosure
Reports First Quarter 2025 Financial Results and Provides Corporate Update
Q3
Q2
Q1
FY 2024
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Free Writing Prospectus
Correspondence